|
|
Seem to see this a lot. Questionable drugs being put on the market..the pandemic was full of snake oil cures that
professionals had already deemed unsafe..ineffective.
"He said the agency’s approval of the drug, aducanumab, which is being marketed as Aduhelm, a monthly intravenous infusion that Biogen has priced at $56,000 per year, was wrong “because of so many different factors, starting from the fact that there’s no good evidence that the drug works.”
Two other members of the committee resigned earlier this week, expressing dismay at the approval of the drug despite the committee’s overwhelming rejection of it after reviewing clinical trial data in November."
| |
|
Three F.D.A. Advisers Resign Over Agency's Approval of Alzheimer's Drug
